SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050817
Filing Date
2020-11-05
Accepted
2020-11-05 06:30:41
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-10q_20200930.htm   iXBRL 10-Q 2392460
2 EX-31.1 sybx-ex311_9.htm EX-31.1 16799
3 EX-31.2 sybx-ex312_7.htm EX-31.2 16738
4 EX-32.1 sybx-ex321_6.htm EX-32.1 6988
5 EX-32.2 sybx-ex322_8.htm EX-32.2 6969
  Complete submission text file 0001564590-20-050817.txt   7290596

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sybx-20200930.xsd EX-101.SCH 39815
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sybx-20200930_cal.xml EX-101.CAL 40611
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sybx-20200930_def.xml EX-101.DEF 161658
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20200930_lab.xml EX-101.LAB 335030
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20200930_pre.xml EX-101.PRE 260197
11 EXTRACTED XBRL INSTANCE DOCUMENT sybx-10q_20200930_htm.xml XML 1306245
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 201288524
SIC: 2834 Pharmaceutical Preparations